Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Nektar Therapeutics NKTR |
BLACKROCK INC BLK |
12,528,006 6.700% |
-3,441,339 (-21.55%) |
Filing History |
| 2025-02-14 1:49 pm Purchase |
2024-12-31 | 13G | Nektar Therapeutics NKTR |
Samlyn Capital, LLC | 9,667,048 5.200% |
9,667,048 (New Position) |
Filing History |
| 2025-02-14 12:08 pm Sale |
2024-12-31 | 13G | Nektar Therapeutics NKTR |
Eventide Asset Management, LLC | 6,650,000 3.610% |
-2,750,000 (-29.26%) |
Filing History |
| 2025-02-14 08:43 am Sale |
2024-12-31 | 13G | Nektar Therapeutics NKTR |
Deep Track Capital, LP | 1,975,998 1.070% |
-13,946,657 (-87.59%) |
Filing History |
| 2024-11-14 12:17 pm Purchase |
2024-09-30 | 13G | Nektar Therapeutics NKTR |
Eventide Asset Management, LLC | 9,400,000 5.110% |
9,400,000 (New Position) |
Filing History |
| 2024-11-14 09:18 am Sale |
2024-09-30 | 13G | Nektar Therapeutics NKTR |
Deep Track Capital, LP | 15,922,655 8.650% |
-2,477,345 (-13.46%) |
Filing History |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Nektar Therapeutics NKTR |
BLACKROCK INC BLK |
15,969,345 8.700% |
0 (Unchanged) |
Filing History |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Nektar Therapeutics NKTR |
BLACKROCK INC BLK |
15,969,345 8.700% |
7,365,023 (+85.60%) |
Filing History |
| 2024-03-15 4:18 pm Purchase |
2024-03-06 | 13G | Nektar Therapeutics NKTR |
TCG Crossover GP II, LLC | 20,046,350 9.900% |
20,046,350 (New Position) |
Filing History |
| 2024-02-14 5:03 pm Sale |
2023-12-31 | 13G | Nektar Therapeutics NKTR |
RA Capital Management, L.P. | 0 0.000% |
-18,700,000 (Position Closed) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | Nektar Therapeutics NKTR |
Citadel Advisors LLC | 5,635,132 3.000% |
-4,094,620 (-42.08%) |
Filing History |
| 2024-02-14 08:50 am Purchase |
2023-12-31 | 13G | Nektar Therapeutics NKTR |
Deep Track Capital, LP | 18,400,000 9.650% |
6,097,763 (+49.57%) |
Filing History |
| 2024-02-13 5:09 pm Sale |
2023-12-29 | 13G | Nektar Therapeutics NKTR |
The Vanguard Group | 12,042,873 6.310% |
-13,314 (-0.11%) |
Filing History |
| 2023-08-17 4:30 pm Purchase |
2023-08-07 | 13G | Nektar Therapeutics NKTR |
RA Capital Management, L.P. | 18,700,000 9.800% |
18,700,000 (New Position) |
Filing History |
| 2023-07-10 2:09 pm Sale |
2023-07-10 | 13G | Nektar Therapeutics NKTR |
Invesco Ltd. IVZ |
5,535,430 2.900% |
-31,792,043 (-85.17%) |
Filing History |
| 2023-07-10 10:41 am Sale |
2023-06-30 | 13G | Nektar Therapeutics NKTR |
The Vanguard Group | 12,056,187 6.370% |
-11,009,588 (-47.73%) |
Filing History |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Nektar Therapeutics NKTR |
BLACKROCK INC BLK |
8,604,322 4.500% |
-9,696,352 (-52.98%) |
Filing History |
| 2023-07-07 1:28 pm Sale |
2023-06-30 | 13G | Nektar Therapeutics NKTR |
PRIMECAP MANAGEMENT CO | 8,149,876 4.310% |
-7,509,177 (-47.95%) |
Filing History |
| 2023-07-03 4:02 pm Purchase |
2023-06-23 | 13G | Nektar Therapeutics NKTR |
Citadel Advisors LLC | 9,729,752 5.100% |
9,729,752 (New Position) |
Filing History |
| 2023-05-05 11:52 am Sale |
2023-04-30 | 13G | Nektar Therapeutics NKTR |
BLACKROCK INC BLK |
18,300,674 9.700% |
-17,627,419 (-49.06%) |
Filing History |